Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

823.82
+24.743.10%
Post-market: 823.820.00000.00%17:24 EDT
Volume:682.44K
Turnover:558.73M
Market Cap:84.82B
PE:20.37
High:824.63
Open:808.86
Low:804.32
Close:799.08
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.05
T/O Rate:0.69%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.67
PE(LYR):19.86

Loading ...

Drug Maker Regeneron Gains After Upbeat Q2 Results

Reuters
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Stock Track | Regeneron Pharmaceuticals Soars 5.69% in Pre-market as Q2 Earnings Blow Past Estimates

Stock Track
·
Jul 30

Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 Vs. IBES Estimate USD 10.3

Reuters
·
Jul 30

Regeneron Q2 FY26 GAAP EPS Falls 5% to $12.23; Revenue Rises 17% to $4.3 Billion

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 4.25% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Q2 Adj. EPS $14.29 Beats $10.26 Estimate, Sales $4.291B Beat $3.816B Estimate

Benzinga Earnings
·
Jul 30

Regeneron Pharmaceuticals - Q2 Eylea Hd U.S. Net Sales up 52% to $596 Mln

THOMSON REUTERS
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 VS. Ibes Estimate USD 10.3

THOMSON REUTERS
·
Jul 30

Regeneron Outlook FY Capex USD 1,030-1,100 Million

THOMSON REUTERS
·
Jul 30

Regeneron Pharmaceuticals - Q2 Dupixent Global Net Sales Rise 38% to $6 Bln

THOMSON REUTERS
·
Jul 30

Sanofi Drug Pipeline Worries, Dupixent Dependence Shake Shares

Reuters
·
Jul 30

Regeneron Pharmaceuticals Lawsuit Alleges Investors Were Misled Before REGN Stock Drops

TIPRANKS
·
Jul 29

Movement Alert|Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings

Market Focus
·
Jul 28

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Movement Alert|Regeneron Pharmaceuticals Rises 3.08% in Regular Trading, Trading at $676.44

Market Focus
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Telix-Regeneron Radiopharma Deal and Lawsuit Could Be A Game Changer For Regeneron Pharmaceuticals (REGN)

Simply Wall St.
·
Jul 27